Splenic marginal zone B-cell lymphoma (SMZL) is a heterogeneous clinico-biological entity.
The clinical course is variable, multiple genes are mutated with no unifying mechanism, and …

Splenic marginal zone lymphoma (SMZL) is a rare B-cell malignancy involving the spleen,
bone marrow, and frequently the blood. SMZL lymphomagenesis involves antigen and/or …

Splenic marginal zone lymphoma (SMZL) is an indolent small B-cell lymphoma involving the
spleen and bone marrow characterized by a micronodular tumoral infiltration that replaces …

The aims of this systematic review are to refine the catalogue of somatic variants in splenic
marginal zone lymphoma (SMZL) and to provide a well-annotated, manually curated …

Splenic marginal zone lymphoma (SMZL) is a newly recognized lymphoma type whose
precise molecular pathogenesis is still essentially unknown. This hampers differential …

Splenic marginal zone lymphoma (SMZL) is a specific low-grade small B-cell lymphoma that
is incorporated in the World Health Organization classification. Characteristic features are …

Splenic marginal zone lymphoma (SMZL) is an indolent B cell malignancy usually involving
spleen, bone marrow and blood. The disease presents as an incidental finding or with …

Since the initial description of splenic marginal zone lymphoma (SMZL) in 1992, an
increasing number of publications have dealt with multiple aspects of SMZL diagnosis …

This study aimed to correlate the frequency of somatic mutations in the IgVH gene and the
use of specific segments in the VH repertoire with the clinical and characteristic features of a …

Splenic marginal zone lymphoma (SMZL) is a B-cell neoplasm whose molecular
pathogenesis remains fundamentally unexplained, requiring more precise diagnostic …